BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26160881)

  • 1. Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer.
    Sundström K; Ploner A; Arnheim-Dahlström L; Eloranta S; Palmgren J; Adami HO; Ylitalo Helm N; Sparén P; Dillner J
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26160881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix.
    Sundström K; Eloranta S; Sparén P; Arnheim Dahlström L; Gunnell A; Lindgren A; Palmgren J; Ploner A; Sanjeevi CB; Melbye M; Dillner J; Adami HO; Ylitalo N
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2469-78. PubMed ID: 20671136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of HPV16 viral load and risk of in situ and invasive squamous cervical cancer.
    Sundström K; Ploner A; Dahlström LA; Palmgren J; Dillner J; Adami HO; Ylitalo N; Sparén P
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):150-8. PubMed ID: 23155137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ.
    Ylitalo N; Josefsson A; Melbye M; Sörensen P; Frisch M; Andersen PK; Sparén P; Gustafsson M; Magnusson P; Pontén J; Gyllensten U; Adami HO
    Cancer Res; 2000 Nov; 60(21):6027-32. PubMed ID: 11085523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
    Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
    N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions.
    Liaw KL; Glass AG; Manos MM; Greer CE; Scott DR; Sherman M; Burk RD; Kurman RJ; Wacholder S; Rush BB; Cadell DM; Lawler P; Tabor D; Schiffman M
    J Natl Cancer Inst; 1999 Jun; 91(11):954-60. PubMed ID: 10359548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of human papillomavirus and risk of cervical adenocarcinoma.
    Dahlström LA; Ylitalo N; Sundström K; Palmgren J; Ploner A; Eloranta S; Sanjeevi CB; Andersson S; Rohan T; Dillner J; Adami HO; Sparén P
    Int J Cancer; 2010 Oct; 127(8):1923-30. PubMed ID: 20473898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study.
    Ylitalo N; Sørensen P; Josefsson AM; Magnusson PK; Andersen PK; Pontén J; Adami HO; Gyllensten UB; Melbye M
    Lancet; 2000 Jun; 355(9222):2194-8. PubMed ID: 10881892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.
    Castle PE; Wacholder S; Lorincz AT; Scott DR; Sherman ME; Glass AG; Rush BB; Schussler JE; Schiffman M
    J Natl Cancer Inst; 2002 Sep; 94(18):1406-14. PubMed ID: 12237286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study.
    Lei J; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Andrae B; Elfström KM; Dillner J; Sparén P; Sundström K
    PLoS Med; 2018 Oct; 15(10):e1002666. PubMed ID: 30273338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution of human papillomavirus genotypes in cervical cancer and intraepithelial neoplasia lesions among Chinese women in Yunnan Province.
    Yuanyue L; Baloch Z; Yasmeen N; Tao Y; Xiaomei W; Xueshan X
    J Infect Public Health; 2018; 11(1):105-110. PubMed ID: 28697900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus and the long-term risk of cervical neoplasia.
    van der Graaf Y; Molijn A; Doornewaard H; Quint W; van Doorn LJ; van den Tweel J
    Am J Epidemiol; 2002 Jul; 156(2):158-64. PubMed ID: 12117707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of vaginal, vulvar and anal precancer and cancer according to high-risk HPV status in cervical cytology samples.
    Lindquist S; Frederiksen K; Petersen LK; Kjær SK
    Int J Cancer; 2024 Jul; 155(1):61-70. PubMed ID: 38418719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women.
    Jia M; Han J; Hang D; Jiang J; Wang M; Wei B; Dai J; Zhang K; Guo L; Qi J; Ma H; Shi J; Ren J; Hu Z; Dai M; Li N
    Tumour Biol; 2016 Jun; 37(6):8019-25. PubMed ID: 26711785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study.
    Josefsson AM; Magnusson PK; Ylitalo N; Sørensen P; Qwarforth-Tubbin P; Andersen PK; Melbye M; Adami HO; Gyllensten UB
    Lancet; 2000 Jun; 355(9222):2189-93. PubMed ID: 10881891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.
    Zielinski GD; Snijders PJ; Rozendaal L; Voorhorst FJ; van der Linden HC; Runsink AP; de Schipper FA; Meijer CJ
    Br J Cancer; 2001 Aug; 85(3):398-404. PubMed ID: 11487272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus type 16 genomic variation in women with subsequent in situ or invasive cervical cancer: prospective population-based study.
    Arroyo-Mühr LS; Lagheden C; Hultin E; Eklund C; Adami HO; Dillner J; Sundström K
    Br J Cancer; 2018 Oct; 119(9):1163-1168. PubMed ID: 30344308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Region-wise distribution of high-risk human papillomavirus types in squamous cell carcinomas of the cervix in India.
    Pillai RM; Babu JM; Jissa VT; Lakshmi S; Chiplunkar SV; Patkar M; Tongaonkar H; Reddy KB; Chakka KN; Siddiqui M; Roychoudury S; Abraham P; Peedicayil A; Gnanamony M; Subashini J; Ram TS; Dey B; Singh N; Singh A; Jain SK; Jayshree RS
    Int J Gynecol Cancer; 2010 Aug; 20(6):1046-51. PubMed ID: 20683415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.